logo
16:07 May 29

FDC Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
405.00
-24.55 (-5.72%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

FDC Ltd. Financials

FDC Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
405.00
-24.55 (-5.72%)
16:07 May 29
Quality
image/svg+xml

68/100
High Financial Strength

Valuation
image/svg+xml

37/100
Mid Valuation

Technical

53/100
Technically Neutral

Strength

7

Weakness

4

Opportunity

1

Threats

0

11.32 %

ROE %

9.64 %

ROA %

17.29

EPS

152.64

BVPS

12.96 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
1527.92 1783.75 1942.94 2108.12 2170.93
Operating Expenses +
1274.23 1532.77 1604.41 1783.32 1824.83
Raw Material
595.64 670.93 709.63 708.68 703.97
Increase Decrease in Cost
-65.43 -15.14 -53.48 27.59 6.99
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
343.33 390.9 413.4 482.37 482.55
Miscellaneous Expenses
683.49 656.1 784.98 819.56 886.52
Operating Profit
253.69 250.98 338.53 324.8 346.1
Other Income
76.09 49.86 101.63 90.66 113.52
Depreciation
37.3 38.94 39.92 53.73 59.24
Interest
3.09 4.09 4.03 4.51 4.99
Profit before tax and exceptio..
289.39 257.8 396.22 357.22 395.39
Exceptional Items
0 0 0 0 -20.79
PBT
289.39 257.8 396.22 357.22 374.6
Provision for Taxation
73.23 63.98 91.16 90.43 93.18
Net Profit
216.16 193.83 305.06 266.79 281.42
NET Profit after MI
216.4 194.04 305.22 266.79 281.42
EPS
12.81 11.66 18.58 16.39 17.29
Operating Profit Margin (%)
16.6 14.07 17.42 15.41 15.94
Net Profit Margin (%)
14.16 10.88 15.71 12.66 12.96

FDC Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 69.70 69.70 69.70 69.70 69.70 69.70
FII 2.40 2.30 2.40 2.40 2.60 2.70
Public 6.30 6.30 6.80 7.20 6.30 6.10
Others 21.60 21.70 21.10 20.70 21.40 21.50
Shareholder Shares Holding %
Research 360 logo
Download Our App On: